Climb Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Climb Bio Inc.
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
/ 
Frequently asked questions
To buy Climb Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Climb Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Climb Bio Inc. is CLYM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Climb Bio Inc. has its primary listing on NASDAQ. You can trade Climb Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Climb Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Climb Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Climb Bio Inc..